Evidence map›Paper›PMID 39255321›Full record

ArticlePLoS neglected tropical diseases2024

Abundance and Leishmania infection patterns of the sand fly Psathyromyia cratifer in Southern Mexico.

Ana Celia Montes de Oca-Aguilar, Edith A Fernández-Figueroa, Karina B López-Ávila, Mariela Isabel Pavón-Méndez, Erika I Sosa-Bibiano, Eduardo A Rebollar-Téllez, Jorge A Palacio-Vargas, Brenda García-López, Claudia Rangel-Escareño, Elsy Nalleli Loría-Cervera

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ana Celia Montes de Oca-AguilarImmunology Laboratory, Regional Research Center "Dr. Hideyo Noguchi", Autonomous University of Yucatan, Merida, Yucatan, Mexico.ORCID 0000-0002-2922-1240
Edith A Fernández-FigueroaCore B for Innovation in Precision Medicine, National Institute of Genomic Medicine, Mexico City, Mexico.
Karina B López-ÁvilaImmunology Laboratory, Regional Research Center "Dr. Hideyo Noguchi", Autonomous University of Yucatan, Merida, Yucatan, Mexico.
Mariela Isabel Pavón-MéndezImmunology Laboratory, Regional Research Center "Dr. Hideyo Noguchi", Autonomous University of Yucatan, Merida, Yucatan, Mexico.
Erika I Sosa-BibianoImmunology Laboratory, Regional Research Center "Dr. Hideyo Noguchi", Autonomous University of Yucatan, Merida, Yucatan, Mexico.
Eduardo A Rebollar-TéllezMedical Entomology Laboratory, Invertebrate Zoology Department; Faculty of Biological Sciences, Autonomous University of Nuevo Leon, San Nicolas de los Garza, Nuevo Leon, Mexico.
Jorge A Palacio-VargasDirectorate of Prevention and Health Protection of Health Services of the State of Yucatan, Merida, Mexico.
Brenda García-LópezCore B for Innovation in Precision Medicine, National Institute of Genomic Medicine, Mexico City, Mexico.
Claudia Rangel-EscareñoPopulation Genomics Department, National Institute of Genomic Medicine, Mexico City, Mexico.
Elsy Nalleli Loría-CerveraImmunology Laboratory, Regional Research Center "Dr. Hideyo Noguchi", Autonomous University of Yucatan, Merida, Yucatan, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLocalized cutaneous leishmaniasis (LCL) is a serious public health problem in Southern Mexico. Six species of Phlebotominae (Diptera: Psychodidae) have been found to be infected with Leishmania (Leishmania) mexicana, the causative agent of LCL in the region. However, little is known about the biology and potential participation of Psathyromyia cratifer in the Leishmania transmission cycle in Mexico, and the Americas. The present study provides evidence of temporal infection caused by Leishmania in Psathyromyia cratifer as well as data on its population dynamics in a LCL endemic area during the well-known transmission cycle of Leishmania in Southern Mexico. METHODOLOGY/PRINCIPAL

findingsIndividual specimens of Psathyromyia cratifer were collected in four sites over the course of five months (from November 2020 through March 2021) using animal-baited, human-baited, and light traps. The temporal activity pattern (month + hour) of Psathyromyia cratifer was assessed along with its relationship with environmental variables. Moreover, Leishmania DNA and blood meals were analyzed and detected in female sand flies. This evidenced an infection rate ranging from 8% to 83%, and the record of Homo sapiens and Ototylomys phyllotis as blood hosts of this sand fly species. High abundances of these sand flies in human-baited traps were recorded which revealed the marked anthropophilic behavior of Psathyromyia cratifer. As regards the transmission dynamics of the parasite within the region, it was observed that the potential highest epidemiological risk for Leishmania transmission by Psathyromyia cratifer occurred during the months of January and March.

conclusionThis is the first contribution ever made to both the population dynamic and the temporal Leishmania prevalence patterns in Psathyromyia cratifer. The resulting findings suggest that this sand fly specimen is the sixth potential vector of L. (L.) mexicana in Southern Mexico. Nonetheless, various biology, behavior, and ecology strands are yet to be addressed. The latter, to determine the role it plays in the transmission dynamics of the parasite within the region, and other areas of the country.

Indexed as

Insect VectorsPsychodidaeAnimalsFemaleHumansLeishmaniaLeishmania mexicanaLeishmaniasis, CutaneousMaleMexico

Identifiers

PMID39255321
PMCPMC11414901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.